CTC vs ASCCP Management Guidelines

CTC-AE is a reference and educational tool for clinical researchers, oncologists, and healthcare professionals working with adverse event terminology and oncology performance status scales. The app provides fast, offline access to publicly available standards: • NCI Common Terminology Criteria for Adverse Events (CTC-AE v4.03 and v5.0) • ECOG Performance Status • Karnofsky Performance Status • Lansky Performance Status (pediatric) You can also keep personal reference notes about trials and patients, stored privately in your own iCloud account and synced across your Apple devices. Export your data as CSV at any time. KEY FEATURES • Complete CTC-AE v4.03 and v5.0 terminology with grades and definitions • Color-coded severity grades for quick visual reference • Multi-column layout optimized for iPad • Performance status scales (ECOG, Karnofsky, Lansky) • Personal trial and patient reference notes, stored privately in your own iCloud account and synced across iPhone, iPad, and Mac • CSV export • Optional Face ID / Touch ID protection • Optional name scrambling for on-screen privacy PRIVACY Your reference notes live in your private iCloud container. Arpacore B.V. has no access to this data, and no information is shared with any third party. INTENDED USE CTC-AE is intended for educational and reference purposes only. It is not a medical device. It is not intended to diagnose, prevent, monitor, predict, prognose, or treat any disease, injury, or disability, and does not provide medical advice. All clinical decisions remain the sole responsibility of qualified healthcare professionals. The CTC-AE terminology is published by the U.S. National Cancer Institute and is reproduced here for reference. This app is not affiliated with, endorsed by, or sponsored by the NCI or NIH. CTC-AE is also available natively on Mac, with full sync between your devices.

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.